This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum


  • 00
  • 00
  • 00
  • 00
19-21 March 2024
Westin Miyako KyotoKyoto, Japan

David Craik, PhD
Professor of Biomolecular Structure, Institute for Molecular Bioscience at University of Queensland


David Craik, FAA, FRS, is a group leader and Professor of Chemistry at the Institute for Molecular Bioscience at The University of Queensland, Brisbane, Australia. He obtained his PhD in organic chemistry from La Trobe University in Melbourne, Australia and undertook postdoctoral studies at Florida State and Syracuse Universities before taking up a lectureship at the Victorian College of Pharmacy in 1983. He was appointed Professor of Medicinal Chemistry and Head of School in 1988. He moved to University of Queensland in 1995 to set up a new biomolecular NMR laboratory and is currently the Director of the Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science. His research focuses on applications of cyclic peptides, toxins and NMR in drug design. He is a Fellow of the Royal Society and a Fellow of the Australian Academy of Science, is author of more than 750 papers and has trained 70 PhD students.

Agenda Sessions

  • Advantages of Using Cyclic Peptides as Therapeutics with a Focus on Improving the Properties of Therapeutic Peptides

  • Using Plants as Biofactories to Produce Therapeutic Peptides